Toronto Dominion Bank
BMY icon

Toronto Dominion Bank’s Bristol-Myers Squibb BMY Stock Holding History

Toronto Dominion Bank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3M Buy
170,000
+20,000
+13% +$1.17M 0.01% 618
2025
Q4 		$8.09M Buy
+150,000
New +$7.22M 0.01% 695
2025
Q1 		– Sell
-44,100
Closed -$2.49M – 1548
2024
Q4 		$2.49M Buy
+44,100
New +$2.46M ﹤0.01% 870

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toronto Dominion Bank's BMY Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, selling an estimated $25.1M and leaving 909,773 shares worth $55.2M. The position accounts for 0.08% of the portfolio, ranked #222.

Toronto Dominion Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $146M in Q4 2019. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Toronto Dominion Bank held 909,773 shares of Bristol-Myers Squibb worth $55.2M as of Q1 2026.
  • Toronto Dominion Bank sold 430,738 Bristol-Myers Squibb shares in Q1 2026, an estimated $25.1M.
  • Bristol-Myers Squibb made up 0.08% of Toronto Dominion Bank's portfolio in Q1 2026, its #222 holding.
  • Toronto Dominion Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Bristol-Myers Squibb position peaked at $146M in Q4 2019.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.